An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes

The drug fenofibrate has received major attention as a novel medical treatment for diabetic retinopathy (DR) and other diabetes-induced microvascular complications. This interest stems from two recent large, well-designed clinical trials that demonstrated large reductions in the progression of DR an...

Descripción completa

Detalles Bibliográficos
Autores principales: Noonan, Jonathan E., Jenkins, Alicia J., Ma, Jian-Xing, Keech, Anthony C., Wang, Jie Jin, Lamoureux, Ecosse L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837039/
https://www.ncbi.nlm.nih.gov/pubmed/24264394
http://dx.doi.org/10.2337/db13-0800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837039/
https://www.ncbi.nlm.nih.gov/pubmed/24264394
http://dx.doi.org/10.2337/db13-0800

Ejemplares similares